Morningside Venture Investments Limited and four associated individuals filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 7,228,337 shares of Apnimed, Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: Each reporting person is listed as beneficially owning 7,228,337 shares of Apnimed common stock, par value $0.00001 per share.
  • Percent of class: The 7,228,337 shares represent 17.4% of Apnimed's outstanding common stock, based on 41,630,779 shares outstanding as of September 4, 2026.
  • Direct holdings split: Morningside directly holds 7,152,713 shares, while its wholly-owned subsidiary MVIL, LLC directly holds 75,624 shares, according to the filing.
  • Shared power only: All reporting persons report 0 sole voting power and 0 sole dispositive power; all 7,228,337 shares carry shared voting and shared dispositive power.
  • Four individual filers: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho each filed as a result of their positions as directors of Morningside; each individually disclaims beneficial ownership of the securities.
  • Triggering event date: The date of the event requiring the filing is stated as September 30, 2026.

Morningside Venture and Directors Report Joint 17.4% Position in Apnimed

According to the Schedule 13G filing, Morningside Venture Investments Limited, a British Virgin Islands exempted company, together with four of its directors, reported a combined beneficial ownership position of 7,228,337 shares of Apnimed, Inc. (NASDAQ:APMD) common stock. The filing states that Morningside directly holds 7,152,713 shares and that its wholly-owned subsidiary MVIL, LLC directly holds 75,624 shares, bringing the total to 7,228,337 shares.

The four individual reporting persons - Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho - are identified in the filing as directors of Morningside who "share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC." The filing further states that each of these four individuals "disclaim beneficial ownership of the securities held by Morningside and MVIL, LLC." All five reporting persons report zero sole voting power and zero sole dispositive power over the 7,228,337 shares.

The filing notes that "Morningside is ultimately wholly beneficially owned by a trust over which Adriel Wenbwo Chan and Wong Yuk Lan share authority to remove the trustee." The 17.4% ownership percentage is calculated based on 41,630,779 shares of common stock outstanding as of September 4, 2026, as reported in Apnimed's Quarterly Report on Form 10-Q filed with the SEC on September 8, 2026. The principal business address for all reporting persons is listed as c/o THC Management Services S.A.M., Monaco.

What Was Disclosed

Morningside Venture Investments Limited and four of its directors filed a Schedule 13G reporting shared beneficial ownership of 7,228,337 shares, or 17.4%, of Apnimed, Inc. common stock, with a triggering event date of September 30, 2026.